Today: 2 March 2026
Browse Category

Stock Market 2 October 2025

SoundHound AI Stock Skyrockets on Red Lobster Deal – Is SOUN the Next Big AI Winner or Overhyped?

SoundHound AI (SOUN) Stock Soars on AI Hype: 217% Growth, Major Deals & Can It Topple the Tech Giants?

SoundHound AI shares closed near $17 on Oct. 2, 2025, up about 5% with a market cap around $6.6 billion. Q2 revenue hit a record $42.7 million, up 217% year-over-year, while management raised full-year guidance. In September, SoundHound acquired Interactions and announced deals with Red Lobster and Primary Health Solutions. Short interest stands at roughly 30% of float amid strong retail buzz.
Rigetti Computing’s Quantum Leap: Stock Soars on Breakthroughs and Bold Bets

Rigetti (RGTI) Stock Soars on New Quantum Wins — Breakthrough or Bubble?

Rigetti shares surged about 160% over three months, hitting a 52-week high near $34.40 in late September. The company announced $5.7 million in QPU orders and a $5.8 million Air Force contract, and rolled out a 36-qubit processor. Q2 revenue fell 42% year-over-year to $1.8 million, with a $39.7 million net loss. Most analysts rate the stock a buy, but average targets sit well below current prices.
Sky Is No Limit: Global Satcom Market Set to Soar Through 2035

AST SpaceMobile (ASTS) Stock Skyrockets on New Satellite and Carrier Milestones – Record Highs and $60+ Targets

AST SpaceMobile (NASDAQ: ASTS) hit an all-time high near $61.18 on Oct. 2, 2025, after surging 130% YTD and trading over $1 billion in volume on Oct. 1. The company, valued near $21.6 billion, has secured major carrier deals including Bell Canada and Vodafone, and holds agreements with over 50 mobile operators. ASTS is building large BlueBird satellites, with launches planned every 1–2 months through 2026. Q2 2025 revenue was $1.15 million, with EPS at –$0.41.
Tesla Model 3 vs BYD Seal vs Hyundai Ioniq 6: The Ultimate 2025 EV Showdown—Which One Should You Buy?

Tesla’s Meteoric Momentum: Why Oct. 2, 2025 Could Be a Game‑Changer for TSLA Investors

Tesla closed at $459 on Oct. 2, 2025, down 2.38% from the prior day, with 36 million shares traded. The company delivered 497,099 vehicles in Q3, beating analyst estimates by about 50,000 as buyers rushed to claim expiring U.S. tax credits. Market cap stood at $1.53 trillion, ranking Tesla ninth globally. The P/E ratio reached 243, far above industry averages.
Coinbase (COIN) Stock Crashes in Crypto Sell-Off – Can It Bounce Back?

Coinbase Stock Rally: Performance, News and Regulatory Landscape as of Oct 2 2025

Coinbase Global Inc. traded at $363.70 on Oct. 2, 2025, up 5.06% from the previous close. The company reported Q2 net revenue of $1.42 billion and net income of $1.43 billion, with a 40.87% net margin. A New Jersey judge allowed a shareholder lawsuit over SEC risk disclosures to proceed. The SEC dropped its enforcement action in February, citing a shift in regulatory approach.
Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings (NASDAQ: ONDS) shares surged 460% year-over-year, hitting a 52-week high of $8.58 on Sept. 29, 2025, after major defense orders and a $200M share offering. Q2 revenue reached a record $6.3M, with a net loss of $10.8M. Ondas acquired Apeiro Motion for $12M and took a 51% stake in SPO Smart Precision Optics. Cash on hand stood at $68.6M as of June 30.
Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

SRPT closed at $19.57 on Oct 2, up 6.8% for the day and nearly 16% over the past month, but remains down about 82% year-to-date. The company restructured in July, cutting 500 jobs and pausing some gene therapy trials after FDA safety concerns. Sarepta resumed shipments of Elevidys for ambulatory DMD patients following FDA guidance. Analyst consensus is “Hold,” with price targets ranging from $14 to $39.
Rivian’s $5 Billion Georgia EV Megaplant: A Bold Gamble to Outdrive Tesla, Ford & More

Will Rivian’s Stock Rebound or Crash? October 2025 Deep Dive into RIVN and the EV Industry

Rivian shares fell about 7% to $13.57 on Oct. 2, 2025, after the company cut its 2025 delivery guidance to 41,500–43,500 vehicles. Rivian produced 10,720 vehicles and delivered 13,201 in Q3. The company posted its first positive gross profit of $206 million in early 2025. A $5.8 billion joint venture with Volkswagen was announced to develop new EV technology.
Tawana Resources (TAWNF) 2025 Stock Skyrocket: Lithium Revival or Mirage?

USA Rare Earth (USAR) Stock Soars on $100M Deal – Is the Rally Sustainable?

USA Rare Earth shares hit a record $20.02 on Oct. 2, 2025, after announcing a $100 million cash-and-stock acquisition of UK-based Less Common Metals and a $125 million PIPE financing. Barbara Humpton took over as CEO Oct. 1. USAR reported no revenues but held $128 million in cash and no significant debt as of August. The stock is up about 170% in six months, fueled by the LCM deal and rare-earth sector momentum.
2 October 2025
Diagnex Inc. (DGNX) Stock Skyrockets in 2025 – An Epic ESG Tech Rally and What’s Next

DGNX Stock Report – Why Diginex’s Growth Spree and ESG Focus Could Make or Break Your Portfolio in 2025

Diginex Limited (DGNX) last traded at $14.56 on Nasdaq, unchanged from the previous close, with 9,721 shares in volume on 2 Oct 2025. Market cap estimates range from $2.65 billion (Reuters) to $3.25 billion (StockAnalysis). The company completed an eight-for-one bonus share issue in September and announced deals to acquire Matter DK ApS and partner with iNEED in Indonesia. No Wall Street analyst coverage; AI ratings are mixed.
Solar Rise: Why Solaris Energy Infrastructure, Inc. Is Turning Heads in 2025 – Recent News, Financial Performance and Expert Forecasts

Solar Rise: Why Solaris Energy Infrastructure, Inc. Is Turning Heads in 2025 – Recent News, Financial Performance and Expert Forecasts

Solaris Energy Infrastructure shares rose 47% year-to-date, closing at $42.39 on October 2, 2025. In August, SEI acquired power-control firm HVMVLV to expand its “power-as-a-service” platform. The company finalized a 900 MW joint venture for AI data center power in April and issued $135 million in convertible notes in May. SEI paid $0.12 quarterly dividends and dual-listed on NYSE Texas in July.
Cloud Titans Unleash AI Alliances and Mega-Deals – July 23–24, 2025 Cloud News Roundup

Applied Digital Corporation (APLD) — The Small‐Cap Stock Chasing a Generative‑AI Gold Rush (Oct 2 2025)

Applied Digital shares jumped nearly 19% to $27.33 over two days ending Oct. 2, 2025, after announcing new capacity leases with CoreWeave and amid speculation of deals with a major cloud provider. The company finalized a 150-MW lease at its Polaris Forge 1 campus, raising total leased capacity to 400 MW and projected contracted revenue to $11 billion. APLD plans to report fiscal Q1 2026 results on Oct. 9.
AI Capex Boom at the Crossroads: Are the Hyperscalers Running into Trouble?

AI Capex Boom at the Crossroads: Are the Hyperscalers Running into Trouble?

Morgan Stanley’s Lisa Shalett warns the AI spending surge is nearing its late stages, citing slowing free-cash-flow growth among hyperscalers after capex quadrupled since 2022. She notes most AI infrastructure is funded by mature businesses facing saturation and rising competition. Strategas data shows hyperscalers’ free cash flow could shrink 16% in the next year. Morgan Stanley advises caution on small-cap and unprofitable tech stocks.
Fair Isaac Corp’s 2025 Surge: How a Direct‑to‑Lender Move Disrupted Credit Bureaus and Re‑Energized FICO Stock

Fair Isaac Corp’s 2025 Surge: How a Direct‑to‑Lender Move Disrupted Credit Bureaus and Re‑Energized FICO Stock

FICO shares jumped about 10% in premarket trading on Oct. 2, 2025, after the company announced a Mortgage Direct License Program letting lenders access credit scores directly and cutting per-score fees. The stock closed at $1,512.71 on Oct. 1, down 24% year-to-date. FICO reported Q3 revenue of $536.4 million and non-GAAP EPS of $8.57 in July. Market cap stood at $36.4 billion.
2 October 2025
MicroStrategy (MSTR) on Oct. 2 2025: Why the Bitcoin Treasury King Keeps Making Headlines

MicroStrategy (MSTR) on Oct. 2 2025: Why the Bitcoin Treasury King Keeps Making Headlines

MicroStrategy, now branded as Strategy, closed at $338.41 on Oct. 1, 2025, and traded near $348.33 pre-market Oct. 2. The company held 640,031 bitcoins as of Sept. 29, with a $33.1 billion cost basis. Analysts rated the stock a strong buy in October with a $495.17 average price target. Strategy was excluded from the S&P 500 in September due to volatility and Bitcoin exposure.
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Deadline Looms: Capital One’s $425 Million Settlement Could Put Cash Back in Your Pocket—Here’s What You Need to Know

Capital One agreed to a $425 million settlement over claims it froze interest rates on its “360 Savings” account at 0.30% while offering much higher rates on a similar product. The deal splits funds between cash payments and increased future interest, but 18 state attorneys general say it lets the bank keep over $2 billion in unpaid interest. The Consumer Financial Protection Bureau dropped its lawsuit after the settlement was announced.
2 October 2025
Rising Short Interest and Record Distributions: Inside John Hancock’s Fundamental All Cap Core ETF & Closed‑End Fund Payout Boom

Rising Short Interest and Record Distributions: Inside John Hancock’s Fundamental All Cap Core ETF & Closed‑End Fund Payout Boom

Short interest in the John Hancock Fundamental All Cap Core ETF (JHAC) jumped 8,600% to 8,700 shares between late August and mid-September 2025, with a 3.5-day average to cover. As of October 2025, JHAC traded near $15.39, up 4.35% for the year. John Hancock’s closed-end funds maintained monthly distributions in October. PDT and HTD distributions included 16% and 19% return of capital, respectively.
2 October 2025
Occidental Petroleum’s Big Deal with Berkshire & What’s Ahead: Stock Performance, News and Analysts’ View (October 2 2025)

Occidental Petroleum’s Big Deal with Berkshire & What’s Ahead: Stock Performance, News and Analysts’ View (October 2 2025)

Occidental Petroleum agreed to sell its OxyChem division to Berkshire Hathaway for US$9.7 billion in cash on Oct. 2, aiming to cut debt below US$15 billion. The stock closed at US$47.72 on Oct. 1, down 0.8% for the week. Q2 earnings beat estimates at US$0.39 per share, with production up 11%. Analysts’ average price target is US$54.32, with a “Hold” consensus.
Nebius Group Stock Soars on Microsoft AI Deal, $3B Funding Plan & Analyses: What You Need to Know on 2 October 2025

Nebius Group Stock Soars on Microsoft AI Deal, $3B Funding Plan & Analyses: What You Need to Know on 2 October 2025

Nebius shares surged from $14.29 in October 2024 to $110 by October 2025, nearing their $117.65 high. The company signed a $17.4 billion AI infrastructure deal with Microsoft in September, triggering a 44% stock jump. Q2 2025 revenue doubled to $105.1 million, with net margin at 99.34%. Nebius launched a $3 billion funding round to expand hardware and data centers.
Nebius (NBIS) Stock Rockets on $17B Microsoft AI Deal – Explosive Growth & Outlook Revealed

Biotech Boom: NBIS Surges After Microsoft‑NeoCloud AI Deal – Is a New Bull Market Ahead?

The Nasdaq Biotechnology Index closed at 5,007.41 on Oct. 2, up 2.61%, its highest in over a year. The index traded between 4,911.94 and 5,039.83 and has ranged from 3,568.35 to 5,039.83 over the past 52 weeks. Biotech stocks have been volatile amid U.S. drug-pricing reform uncertainty, but recent AI deals and low valuations have drawn buyers.
Go toTop